Arrowstreet Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,234
Closed -$418K 1496
2022
Q2
$418K Buy
+6,234
New +$418K ﹤0.01% 1089
2021
Q2
Sell
-52,900
Closed -$9.06M 2312
2021
Q1
$9.06M Sell
52,900
-70,650
-57% -$12.1M 0.01% 926
2020
Q4
$27.1M Buy
+123,550
New +$27.1M 0.04% 489
2019
Q4
Sell
-13,715
Closed -$1.07M 1956
2019
Q3
$1.07M Buy
+13,715
New +$1.07M ﹤0.01% 1145